Audited Standalone Financial Results of the company for the half year and year ended on March 31, 2026 along with Auditor''s Report under Reg 33 of SEBI (LODR) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Broach Lifecare Hospital reported total income of Rs 603.67 lakhs for FY26, up 85% from Rs 326.72 lakhs in FY25, driven by revenue from operations growing from Rs 322.52 lakhs to Rs 599.47 lakhs. However, net profit declined sharply to Rs 8.68 lakhs from Rs 53.59 lakhs despite higher revenue, indicating significant cost pressure. Total expenses increased substantially to Rs 582.62 lakhs (vs Rs 250.91 lakhs), with employee costs at Rs 115.70 lakhs and finance costs at Rs 13.10 lakhs. The company raised capital through an IPO during the year, with share capital remaining at Rs 607.04 lakhs. Operating cash flow turned positive at Rs 130.31 lakhs (vs negative Rs 62.18 lakhs in FY25). Auditor issued an unmodified (clean) opinion with no qualifications.
Revenue growth of 86% is impressive, but the 84% decline in net profit raises concerns about cost efficiency and profitability conversion. The stock may face pressure unless investors are convinced the heavy investments (PPE increased from Rs 156.60 lakhs to Rs 454.60 lakhs) will drive future returns.